A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Clinical trial NCT02294682 · COMPLETED
Trial details
- NCT number
- NCT02294682
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-15
- Primary completion
- 2016-07-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.